Pulmonary Arterial Pulmonary Hypertension
GPTKB entity
Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
medical condition |
| gptkbp:abbreviation |
gptkb:PAH
|
| gptkbp:affects |
pulmonary arteries
|
| gptkbp:associatedWith |
HIV infection
portal hypertension congenital heart disease connective tissue diseases drugs and toxins |
| gptkbp:can_be_fatal |
true
|
| gptkbp:can_be_idiopathic |
true
|
| gptkbp:can_be_progressive |
true
|
| gptkbp:canBeManagedBy |
oxygen therapy
lung transplantation diuretics |
| gptkbp:cause |
gptkb:right_heart_failure
dizziness fatigue shortness of breath fainting chest pain |
| gptkbp:characterizedBy |
high blood pressure in the arteries of the lungs
|
| gptkbp:class |
Group 1 pulmonary hypertension
|
| gptkbp:diagnosedBy |
echocardiogram
right heart catheterization |
| https://www.w3.org/2000/01/rdf-schema#label |
Pulmonary Arterial Pulmonary Hypertension
|
| gptkbp:treatment |
vasodilators
phosphodiesterase-5 inhibitors endothelin receptor antagonists prostacyclin analogs |
| gptkbp:type |
pulmonary hypertension
|
| gptkbp:bfsParent |
gptkb:PAPH
|
| gptkbp:bfsLayer |
8
|